Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Consistent Injection Timing Maintaining the same injection day each week helps keep hormone levels stable
Products, pricing and availability may vary by geographical location
Advocate for policy change: Participate in state medical society advocacy efforts to expand Medicaid coverage for anti-obesity medications
Experience safe, doctor-guided weight loss with Semaglutide (GLP-1) designed to reduce appetite, control cravings, and support lasting results
The actual numbers from peer-reviewed research published in the New England Journal of Medicine and presented at major medical conferences
CMS Issues Coverage Guidance on GLP-1 Anti-Obesity Drugs: Implications for Health Plans Posted on April 5, 2024 CMS Issued Coverage Guidance on GLP-1 Anti-Obesity Drugs Requiring Considerations for Health Plans GLP-1s (glucagon-like peptide 1 agonist) came up in the news again after the Centers for Medicare and Medicaid Services (CMS) issued coverage guidance on GLP-1 anti-obesity drugs with expanded indications on March 20, 2024.* Since the inception of Medicare Part D, drugs used for weight loss have been excluded from basic coverage
US$ 20.80
US$ 21.65
US$ 24.29
US$ 26.17
US$ 29.52
